【华领医药-B(02552.HK):张怡获委任为提名委员会成员】智通财经APP讯,华领医药-B(02552.HK)发布公告,自2026年6月25日起,本公司执行董事张怡博士(张博士)及独立非执行董事张耀梁先生(张先生)获委任为提名委员会成员。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.